CHINESE JOURNAL OF DRUG EVALUATION ›› 2026, Vol. 43 ›› Issue (3): 184-184-188.doi: 10.2095-3593.2026.060001

Previous Articles     Next Articles

Research on the Determination Method and Risk Assessment of Aristolochic Acid Ⅰin Xinfang Biyan Capsules

RU Qingguo, LI Haiyan, LIU Yanan, JIANG Ludi, HUANG Xia, WANG Haibo*   

  1. Henan Institute for Drug and Medical Device Control (Henan Vaccine Issuance Center),Henan Province Engineering Research Center of Quality Control of Traditional Chinese Medicine, Henan Zhengzhou 450018, China
  • Received:2026-01-12 Revised:2026-04-22 Accepted:2026-08-05 Online:2026-06-28 Published:2026-08-12

Abstract: Objective: To establish an high performance liquid chromatography-mass spectrometry method for the determination of aristolochic acid Ⅰ in xinfang biyan capsules, and provide theoretical basis for its safety control. Methods:Waters ACQUITY UPLC HSS T3 (2.1 mm×100 mm, 1.8 μm) column was used. Methanol-0.1% formic acid (containing 1 mmol·L-1 ammonium acetate) solution was used as mobile phase, gradient elution, flow rate of 0.3 mL·min-1, positive ion mode of electric spray ion source, multi reaction monitoring, external standard determination. Results: The linear relationship of aristolochic acid I was good within the range of 0.320 9-32.092 5 μg·mL-1 (r2=0.999 5), with an average recovery rate of 95.04%. Aristolochic acid I was detected in all 104 batches of samples, with a content of 7.91-90.75 ng·g-1. Conclusion: This method is sensitive, accurate, reliable, and highly specific, and can be used for the limited detection of aristolochic acid I in xinfang biyan capsules.

Key words: font-size:medium, "> , Xinfang biyan capsules; Aristolochic acid Ⅰ; Safety; High performance liquid chromatography-mass spectrometry; Limit test

CLC Number: 

[an error occurred while processing this directive]